Last night the Welsh Labour MP for Newport West, Jane Bryant led a Senedd debate opening up a vital conversation about drug reform in Wales. This was an incredibly exciting …
drug
-
-
Advocacy NewsIndustry News
Where are we now? A reflection on Cancard and the last 3 years of cannabis legislation.
The first week of November was Medical Cannabis Awareness Week, prompting an excellent time for Volteface to reflect on the past three years since medical cannabis was legalised. In this …
-
You can now listen to this essay as part of the Volteface Audio Long Reads selection. Just click on the link above. Like the thick smoky aftertaste that lingers after …
-
What’s happening? Popular Instagram account @edi_anonymous revealed “multiple reports of spiking by injection in Edinburgh clubs” last week, with The Times reporting that “those claiming to be affected say they …
-
Also referred to by the terms ‘overdose prevention centres’, ‘safe injecting rooms’, ‘safer consumption rooms’, and ‘supervised injection sites’, DCRs are medically supervised sites where people who use drugs are …
-
Data from a YouGov report on the perceived harm of drugs and strategies for their control was released today, offering compelling insights into Britons’ attitudes towards the impact of drug …
-
The House of Commons debate last Monday was a fantastic display of support and solidarity for families, campaigners and advocates alike, all hoping to expand access to medical cannabis that …
-
Home Secretary Priti Patel last week formally asked the Advisory Council on the Misuse of Drugs (ACMD) to “review the harm caused by nitrous oxide”, announcing that the unlawful possession …
-
Freshers has been anything but a normal for those starting university this year. When Libby*, a first-year student rolled up to her halls, she didn’t expect to be locked …
-
Advocacy News
The Overwhelming Argument for Rescheduling Psilocybin to Schedule 2 in the Misuse of Drugs Regulations 2001.
by Rob JappieIn July, the Conservative Drug Policy Reform Group (‘CDPRG’) produced the most compelling argument (so far) for rescheduling of psilocybin.[1] It is now time to: Assess the impact of …